<HashMap><database>biostudies-literature</database><scores/><additional><submitter>White MK</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NIDA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institute of Mental Health</funding><pagination>547-54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4965407</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>The study of neurological infections by viruses defines the field of neurovirology, which has emerged in the last 30 years and was founded upon the discovery of a number of viruses capable of infecting the human nervous system. Studies have focused on the molecular and biological basis of viral neurological diseases with the aim of revealing new therapeutic options. The first studies of neurovirological infections can be traced back to the discovery that some viruses have an affinity for the nervous system with research into rabies by Louis Pasteur and others in the 1880s. Today, the immense public health impact of neurovirological infections is illustrated by diseases such as neuroAIDS, progressive multifocal leukoencephalopathy, and viral encephalitis. Recent research has seen the develo</pubmed_abstract><journal>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</journal><pubmed_title>Gene Editing for Treatment of Neurological Infections.</pubmed_title><pmcid>PMC4965407</pmcid><funding_grant_id>P30 MH092177</funding_grant_id><funding_grant_id>R01 AI077460</funding_grant_id><funding_grant_id>R01NS087971</funding_grant_id><funding_grant_id>P01 DA037830</funding_grant_id><funding_grant_id>R01 NS087971</funding_grant_id><funding_grant_id>P30MH092177</funding_grant_id><pubmed_authors>Khalili K</pubmed_authors><pubmed_authors>Hu W</pubmed_authors><pubmed_authors>White MK</pubmed_authors><pubmed_authors>Kaminski R</pubmed_authors><pubmed_authors>Wollebo H</pubmed_authors><pubmed_authors>Malcolm T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gene Editing for Treatment of Neurological Infections.</name><description>The study of neurological infections by viruses defines the field of neurovirology, which has emerged in the last 30 years and was founded upon the discovery of a number of viruses capable of infecting the human nervous system. Studies have focused on the molecular and biological basis of viral neurological diseases with the aim of revealing new therapeutic options. The first studies of neurovirological infections can be traced back to the discovery that some viruses have an affinity for the nervous system with research into rabies by Louis Pasteur and others in the 1880s. Today, the immense public health impact of neurovirological infections is illustrated by diseases such as neuroAIDS, progressive multifocal leukoencephalopathy, and viral encephalitis. Recent research has seen the develo</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jul</publication><modification>2026-07-15T23:30:03.803Z</modification><creation>2019-03-27T02:19:26Z</creation></dates><accession>S-EPMC4965407</accession><cross_references><pubmed>27150390</pubmed><doi>10.1007/s13311-016-0439-1</doi></cross_references></HashMap>